Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting

Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease even in the early stages, despite progresses in surgical and pharmacological treatment in recent years. High potential for metastases is the main cause of therapeutic failure in localized disease, highlighting the current limited knowledge...

Full description

Bibliographic Details
Main Authors: Annalisa Pappalardo, Emilio Francesco Giunta, Giuseppe Tirino, Luca Pompella, Piera Federico, Bruno Daniele, Ferdinando De Vita, Angelica Petrillo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
PDAC - pancreatic ductal adenocarcinoma
biomarkers
ctDNA = circulating tumor DNA
gemcitabine
predictive factors
PARPi
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.695627/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.695627/full

Similar Items